Discussion on Bufei Decoction in the treatment of stable COPD based on theory of "Latent Toxin Entering Lung"
10.3760/cma.j.cn115398-20220913-00158
- VernacularTitle:基于“伏毒蕴肺”探讨补肺汤治疗慢性阻塞性肺疾病稳定期
- Author:
Wen ZHANG
1
;
Qiong ZHANG
;
Yi HE
;
Muyang JIN
;
Xinyu ZHANG
;
Ruiling ZHOU
Author Information
1. 北京市朝阳区中医医院内科，北京 100020
- Keywords:
Pulmonary disease, chronic obstructive;
Latent Toxin;
Simultaneous treatment of the symptoms and root cause;
Bufei Decoction;
Pathogenesis (TCM)
- From:
International Journal of Traditional Chinese Medicine
2023;45(11):1345-1349
- CountryChina
- Language:Chinese
-
Abstract:
Chronic obstructive pulmonary disease (COPD) is characterized by excess in nature and deficiency in superficiality. For COPD patients, the deficiency of lung and kidney is the basis for production of the latent toxin, and repeated exogenous infection is the main factor for the latent toxin to enter the lung. The key pathogenesis of stable COPD is the entry of latent toxin into the lung and the injury of lung and collaterals. Therefore, tonifying lung and kidney, removing toxins and dredging collaterals are the core treatment methods for COPD in stable period. Bufei Decoction is with good efficacy in the treatment of COPD in stable period, which can not only tonify lung and kidney to consolidate, but also dredging collaterals to remove toxins. Based on the pathogenesis of "latent toxin entering lung", the relevant mechanisms of Bufei Decoction in treating stable COPD were further understood and explored, in order to benefit clinical practice.
